Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Plain-language comparison of plasma-treated vs HF-etched lithium disilicate crowns

Official title: Effect of Innovative Treatment With Atmospheric-Pressure Gaseous Plasma on the Clinical Success and Survival of Full- and Partial-Coverage Dental Crowns Made of Lithium Disilicate Ceramic

Run by University of Ljubljana, Faculty of Medicine · NCT07876167 · Data updated 2026-11-12

This study tests whether air-plasma treatment on lithium disilicate crowns works as well as the standard hydrofluoric acid etching before cementing them to teeth.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity of Ljubljana, Faculty of Medicine
Academic / other
Locations1 site (Ljubljana)
StatusRecruiting
StartedSeptember 2026
Main results expectedSeptember 2029
Study endsOctober 2030
Registry record updatedOctober 15, 2026
Trial IDNCT07876167 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults requiring posterior partial- or full-coverage lithium disilicate crowns and meeting good oral hygiene and general health criteria.

Probably not a fit

Patients with active periodontal disease, dentin hypersensitivity, or contraindications to prosthodontic treatment may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind trial compares two surface-treatment methods for lithium disilicate crowns placed on posterior teeth: atmospheric-pressure nonthermal plasma (APP) pretreatment versus conventional hydrofluoric acid (HF) etching. Adults needing partial- or full-coverage LDC crowns are assigned to one of the pretreatments before adhesive cementation, with follow-up visits at 1 week, and 1, 3, 6, and 12 months to assess crown survival and oral-health-related quality of life. The study aims to determine if APP can provide comparable or superior clinical performance and bonding compared with HF etching, while reducing HF-related safety concerns. Outcomes include clinical success, crown survival, and patient-reported quality of life. The trial is sponsored by the University of Ljubljana and involves multiple Slovenian institutions.

Why it matters

Potential benefit: If successful, APP pretreatment could offer a safer or equally effective alternative to HF etching for lithium disilicate crowns.

How similar studies have gone: Preclinical and early clinical work suggested APP can modify ceramic surfaces, but long-term clinical outcomes with APP are not yet well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* No systemic contraindications to prosthodontic treatment
* Adequate oral hygiene
* Signed informed consent to participate in the study
* Posterior teeth (premolars or molars)
* Involvement of the entire occlusal surface
* Partial- or full-coverage lithium disilicate ceramic restoration
* Vital and healthy dental pulp

Exclusion Criteria:

* Orofacial pain
* Allergy to latex, dental composites, or acrylates
* Pregnancy or breastfeeding
* Clinical signs of periodontal or periapical inflammation
* Dentin hypersensitivity
* Pain on biting or spontaneous pain
* Pathological findings on dental radiographs
* Untreated periodontal disease
* Hypoplastic enamel defects

Where it's running

  • Faculty of Medicine, University of Ljubljana
    Ljubljana, Slovenia
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.